Skip to main content
Hyung Kim, MD, Urology, Los Angeles, CA, Cedars-Sinai Medical Center

HyungKimMD

Urology Los Angeles, CA

Minimally Invasive Surgery, Surgical Oncology

Director, Academic Urology Program Associate Director, Surgical Research in the Samuel Oschin Comprehensive Cancer Institute Medallion Group Chair in Urology Co-Medical Director, Urologic Oncology Center

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kim's full profile

Already have an account?

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Minimally Invasive Urologic Surgery, 2003 - 2004
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Urologic Surgical Oncology, 2002 - 2003
  • University of Chicago
    University of ChicagoResidency, Urology, 1996 - 2002
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1996
  • University of Michigan
    University of MichiganB.S., 1989 - 1992

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2025
  • NY State Medical License
    NY State Medical License 2004 - 2019
  • IL State Medical License
    IL State Medical License 2001 - 2002
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Homer and Gloria Harvey Family Chair in Urologic Oncology in Honor of Stuart Friedman, M.D. Cedars Sinai Medical Center, 2018
  • Essay Contest, 1st place AUA annual meeting, 2010
  • Winnick research award 2010
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Hao Zhang H., Berel, D., Wang, Y., Figlin, R.A., Kim, H.L., PlosOne, 1/1/2013
  • Brewer K., O'Malley R.L., Hayn M., Safwat M.W., Kim H.L. Underwood W., Schwaab T., J Endourol, 3/1/2012
  • O'Malley R.L., Hayn M.H., Hellenthal N.J., Kim H.L., Underwood W., Schwaab T., Can J Urol, 2/1/2012
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • O'Malley, R.L., Brewer, K.A., Hayn, M.A., Poch, M.A.., Kim, H.L., Schwaab, T., Journal of Urology, 1/1/2011
  • O'Malley, R.L., Hayn, M.A., Kim, H.L., Brewer, K.A., Poch, M.A., Schwaab, T., Journal of Urology, 1/1/2011
  • O'Malley, R.L., Hayn, M.A., Brewer, K.A., Poch, M.A., Kim, H.L., Schwaab, T., Journal of Urology, 1/1/2011
  • Join now to see all

Lectures

  •  
    Genitourinary Cancers Symposium sponsored by ASCO/ASTRO/SUO. Orlando, FL - 2/1/2013
  •  
    RCC Task force. Orlando, FL - 2/1/2013
  •  
    national meeting for Society of Urologic Oncology. Bethesda, MD - 11/1/2012
  • Join now to see all

Other

  •  
    Figlin, R.A., Kim, H.L.
    Clinical Care Options, LLC. Brooklyn, NY - 1/1/2006
  •  
    Schulam, P., Kim, H.L.
    Cine Clinic I Multispecialty/endoscopic CD, 2003, Woodbury, CT - 1/1/2003

Press Mentions

  • Prognostic Value of Soluble ST2 and Soluble LR11 on Mortality and Cardiovascular Events in Peritoneal Dialysis Patients
    Prognostic Value of Soluble ST2 and Soluble LR11 on Mortality and Cardiovascular Events in Peritoneal Dialysis PatientsJune 15th, 2020
  • Presents State of Science Summit
    Presents State of Science SummitFebruary 21st, 2018

Grant Support

  • R01NCI/NHI2008–Present
  • K23NCI/NIH2007–2012

Professional Memberships

Other Languages

  • Korean

Hospital Affiliations